These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 37907036)
1. Comparison of tandospirone and escitalopram as a symptomatic treatment in Multiple System Atrophy-cerebellar ataxia: An open-label, non-controlled, 4 weeks observational study. Quan M; Gao J; Xu S; Guo D; Jia J; Wang W J Psychiatr Res; 2023 Dec; 168():133-139. PubMed ID: 37907036 [TBL] [Abstract][Full Text] [Related]
2. A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China. Chen H; Lin Q; Lin T; Lin Y; Lin X; Chen R; Luo L; Lin F; Xiao Y J Psychiatr Res; 2019 Jul; 114():133-140. PubMed ID: 31075722 [TBL] [Abstract][Full Text] [Related]
3. Augmentation therapy with tandospirone citrate in vascular depression patients with mild cognitive impairment: A prospective randomized clinical trial. Chen R; Lin Q; Wu J; Lin Y; Lin T; Wu W; Chen X; Wu S; Zeng G; Lin X; Wu Y; Liu N; Xiao Y; Chen H J Psychiatr Res; 2023 Mar; 159():274-282. PubMed ID: 36774768 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Different Symptom Assessment Scales for Multiple System Atrophy. Matsushima M; Yabe I; Oba K; Sakushima K; Mito Y; Takei A; Houzen H; Tsuzaka K; Yoshida K; Maruo Y; Sasaki H Cerebellum; 2016 Apr; 15(2):190-200. PubMed ID: 26093615 [TBL] [Abstract][Full Text] [Related]
5. Neuropsychological and clinical heterogeneity of cognitive impairment in patients with multiple system atrophy. Barcelos LB; Saad F; Giacominelli C; Saba RA; de Carvalho Aguiar PM; Silva SMA; Borges V; Bertolucci PHF; Ferraz HB Clin Neurol Neurosurg; 2018 Jan; 164():121-126. PubMed ID: 29223069 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time. Damon-Perrière N; Foubert-Samier A; De Cock VC; Gerdelat-Mas A; Debs R; Pavy-Le Traon A; Senard JM; Rascol O; Tison F; Meissner WG Parkinsonism Relat Disord; 2012 Jun; 18(5):612-5. PubMed ID: 22236582 [TBL] [Abstract][Full Text] [Related]
7. Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label study. Takei A; Hamada S; Homma S; Hamada K; Tashiro K; Hamada T Cerebellum; 2010 Dec; 9(4):567-70. PubMed ID: 20809107 [TBL] [Abstract][Full Text] [Related]
8. Natural history of multiple system atrophy in the USA: a prospective cohort study. Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular autonomic testing in the work-up of cerebellar ataxia: insight from an observational single center study. Indelicato E; Fanciulli A; Nachbauer W; Eigentler A; Amprosi M; Ndayisaba JP; Granata R; Wenning G; Boesch S J Neurol; 2020 Apr; 267(4):1097-1102. PubMed ID: 31893293 [TBL] [Abstract][Full Text] [Related]
10. [Sporadic Cerebellar Ataxia: Multiple System Atrophy and Mono System Atrophy]. Watanabe H; Ito M; Mizutani Y; Ueda A; Shima S Brain Nerve; 2020 Sep; 72(9):931-937. PubMed ID: 32934182 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and quality of life in Chinese patients with multiple system atrophy. Du JJ; Wang T; Huang P; Cui S; Gao C; Lin Y; Fu R; Zhou H; Chen S Brain Behav; 2018 Dec; 8(12):e01135. PubMed ID: 30378279 [TBL] [Abstract][Full Text] [Related]
12. [New MDS Criteria for the Diagnosis of Multiple System Atrophy: An Autonomic Viewpoint]. Sakakibara R; Sawai S; Ogata T Brain Nerve; 2023 Feb; 75(2):123-132. PubMed ID: 36750210 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients with vascular depression accompanied by somatic symptoms: An open-labeled randomized control trial. Chen H; Lin Y; Zhao Z; Lin T; Lin Q; Chen X; Wu W; Zeng G; Wu S; Liu N; Chen H; Chen R; Xiao Y CNS Neurosci Ther; 2024 Mar; 30(3):e14650. PubMed ID: 38514905 [TBL] [Abstract][Full Text] [Related]
14. Is multiple system atrophy with cerebellar ataxia (MSA-C) like spinocerebellar ataxia and multiple system atrophy with parkinsonism (MSA-P) like Parkinson's disease? - A saccade study on pathophysiology. Terao Y; Fukuda H; Tokushige S; Inomata-Terada S; Yugeta A; Hamada M; Ichikawa Y; Hanajima R; Ugawa Y Clin Neurophysiol; 2016 Feb; 127(2):1491-1502. PubMed ID: 26350408 [TBL] [Abstract][Full Text] [Related]
15. Impact of sleep-related breathing disorder on motor and non-motor symptoms in multiple system atrophy. Cao B; Wei QQ; Ou R; Zhao B; Hu T; Chen Y; Yang J; Lei F; Tang X; Shang HF Sleep Breath; 2018 Dec; 22(4):981-987. PubMed ID: 29380098 [TBL] [Abstract][Full Text] [Related]
16. Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study. Lin J; Su Y; Wang C; Yang F; Xu Y; Yuan Y; Yuan Y; Wang X; Yu X; Si T J Psychiatr Res; 2018 Apr; 99():104-110. PubMed ID: 29433063 [TBL] [Abstract][Full Text] [Related]
18. Subthalamic nucleus-deep brain stimulation improves autonomic dysfunctions in Parkinson's disease. Zhang F; Wang F; Li CH; Wang JW; Han CL; Fan SY; Gao DM; Xing YJ; Yang C; Zhang JG; Meng FG BMC Neurol; 2022 Mar; 22(1):124. PubMed ID: 35361123 [TBL] [Abstract][Full Text] [Related]
19. Repetitive transcranial magnetic stimulation of the cerebellum improves ataxia and cerebello-fronto plasticity in multiple system atrophy: a randomized, double-blind, sham-controlled and TMS-EEG study. Song P; Li S; Wang S; Wei H; Lin H; Wang Y Aging (Albany NY); 2020 Oct; 12(20):20611-20622. PubMed ID: 33085647 [TBL] [Abstract][Full Text] [Related]
20. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia. Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]